- Conditions
- Astigmatism
- Interventions
- DT1fA
- Device
- Lead sponsor
- Keith Wan
- Other
- Eligibility
- 18 Years to 38 Years
- Enrollment
- 86 participants
- Timeline
- 2022
- U.S. locations
- 1
- States / cities
- San Diego, California
Source: ClinicalTrials.gov public record
Updated Sep 18, 2024 · Synced May 22, 2026, 1:12 AM EDT